Sep 17, 2026 04:01PM
Sep 17, 2026 04:01PM
Aug 10, 2026 06:41AM
Aug 6, 2026 04:01PM
May 7, 2026 04:01PM
Apr 19, 2026 06:00PM
Apr 19, 2026 06:00PM Xenon presents positive Phase 3 epilepsy trial results at neurology meeting
Apr 19, 2026 06:00PM
Apr 19, 2026 06:00PM
Mar 9, 2026 09:18AM
Mar 9, 2026 07:00AM
Mar 9, 2026 07:00AM
Dec 19, 2025 09:06AM
Nov 16, 2025 03:00PM Where can biotech stocks go from here? RBC answers
Sep 11, 2025 08:18AM
Jul 29, 2025 06:30AM
Jul 29, 2025 06:30AM
Apr 12, 2025 04:00AM
Jan 6, 2025 10:35AM
Dec 21, 2024 10:00AM
May 9, 2024 04:01PM Xenon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
Feb 29, 2024 04:01PM
May 9, 2023 04:01PM
Jan 9, 2023 08:13AM
Jan 9, 2023 08:00AM
Jan 9, 2023 08:00AM
Nov 8, 2022 04:01PM
Nov 8, 2022 04:01PM Xenon Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Nov 3, 2022 08:30AM
Nov 3, 2022 08:30AM
Aug 9, 2022 04:01PM
Aug 9, 2022 04:01PM
Jun 21, 2022 07:01AM
Jun 21, 2022 07:00AM
Jun 21, 2022 07:00AM Xenon Pharmaceuticals Announces Positive Outcome of End-of-Phase 2 Meeting with the FDA
May 10, 2022 04:01PM
May 10, 2022 04:01PM
Apr 12, 2022 06:37AM
Mar 1, 2022 04:01PM
Mar 1, 2022 04:01PM
Jan 19, 2022 06:04PM
Jan 12, 2022 08:04AM Xenon Pharmaceuticals (XENE) Collaboration with Neurocrine (NBIX) Biosciences Achieves $15M Regulatory Milestone
Jan 12, 2022 08:01AM
Jan 12, 2022 08:00AM
Jan 12, 2022 08:00AM
Jan 10, 2022 08:34AM
Jan 10, 2022 08:30AM
Jan 10, 2022 08:30AM
Dec 3, 2021 07:01AM Xenon Pharmaceuticals (XENE) Reports Additional Positive Data from Phase 2b ‘X-TOLE’ Trial
Dec 3, 2021 07:00AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All